NEWS

Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral oc...

Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature Plano, Texas - (September 4, 2024)Vesalio announces the U.S. commercialization of pVasc™ Thrombectomy System for non-surgically removing peripheral occlusions. pVasc targets the full range of embolisms from soft, acute clots to fibrin-rich, calcified ones, enabling a fast and safe removal. Its unique Drop Zone™ technology traps, retains and securely removes thrombus to restore flow in patients suffering from acute limb ischemia (ALI) and other conditions related to peripheral artery disease (PAD).  

Penumbra symposium - The power of dedicated technologies for distal occlusions

In Memoriam: Jean-Claude Lechien

Micro-neuroangiography of the ACom complex and perforators

Confusing arteries with veins

Low NIHSS thrombectomy: benefit risk balance of GA

Flow DiVeRter - current and future prospects

Delayed and distal thrombectomy still beneficial

VESALIO introduces NeVa NET 4.0 mm following international success of Ne...

In NeVa NET™, Distal Embolic Filtration and Drop Zone™ technologies work together to enhance clot capture and retention, providing effective recanalization in ischemic stroke thrombectomy. The new NeVa NET 4.0, following the success of the 5.5 mm version, is designed to offer clinicians an advanced tool for improving first-pass rates and reducing distal embolization.

Sensome signs exclusive commercial distribution agreement for clot-sensi...

First distribution agreement for Sensome’s smart clot-sensing guidewire technology used in ischemic stroke treatment.Cosmotec to make upfront equity investment in Sensome